Cancer is a multistep phenomenon and multiple genetic lesions are invo
lved in the lesion. This has best been demonstrated in colonic cancer.
The authors review their work and that of others highlighting what is
known about thyroid cancer. They implicate uns mutations predominantl
y in follicular in papillary carcinoma and the tumor suppressor genes
p53 and retinoblastoma gene product in all stages of thyroid carcinoma
. They find a low rate of ret proto-oncogene rearrangement in the Saud
i population (>5%) as compared to elsewhere in the world (20%). They f
ind TSH receptor message abundance to be predictive of prognosis in th
yroid cancer patients. Lastly, they examine whether the abundance of t
he antimetastatic gene nm23 message abundance negatively correlated wi
th the tendency of thyroid tumors to metastasize and find that not to
be the case in thyroid carcinoma. The study of oncogenes and tumor sup
pressor genes in the pathogenesis of thyroid cancer is in its infancy;
however, rapid progress is being made in identifying genes participat
ing in malignant thyroid cell transformation.